๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Prostatic Neoplasms
Clinical trial register · Sweden

Prostatic Neoplasms Trials in Sweden, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Sweden and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 2213 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:46 UTC
2213
Studies in scope
all four open statuses
1238
Recruiting now
open to new participants
367
Lead sponsors
across recruiting studies
Top sites
Stockholm 9 Gothenburg 6 Malmรถ 4 ร–rebro 3 Uppsala 3
Narrow the registerReset
Recruitment status
Phase
Site location
Stockholm9 Gothenburg6 Malmรถ4 ร–rebro3 Uppsala3
All 13 locations
Target enrolment
to

Prostatic Neoplasms trials in Sweden

11 of 2213 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Sweden
Start
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
NCT06925737Prostate Cancer, Prostatic Neoplasms
Merck Sharp & Dohme LLC
Phase 3
1,440
Malmรถ, Stockholm, Uppsala
2025-05-13
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
NCT06136650Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Merck Sharp & Dohme LLC
Phase 3
1,314
Stockholm, Uppsala
2023-12-18
Recruiting
Lymphedema After Urologic Surgery
NCT05264337Urinary Bladder Neoplasms, Prostatic Neoplasms, Testicular Neoplasms, Penile Cancer
Vastra Gotaland Region
Observational
400
Gothenburg, ร–rebro
2022-03-14
Active, closed
177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer
NCT04689828Prostatic Neoplasms
Novartis Pharmaceuticals
Phase 3
469
Gothenburg, Lund, Stockholm
2021-06-15
Active, closed
A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer
NCT04577833Prostatic Neoplasms
Janssen Research & Development, LLC
Phase 1
136
Stockholm
2020-11-13
Active, closed
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer
NCT04557059Prostatic Neoplasms
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Malmรถ, Stockholm
2020-11-12
Active, closed
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
NCT02531516Prostatic Neoplasms
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
ร–rebro, Stockholm, Umeรฅ
2015-11-19
Recruiting
Surgery Versus Radiotherapy for Locally Advanced Prostate Cancer
NCT02102477Prostatic Neoplasms
Olof Akre
Not applicable
1,200
Falun, Gothenburg, Helsingborg, Jรถnkรถping, Karlskrona, Linkรถping, Malmรถ, Norrkรถping
2014-10
Active, closed
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
NCT01946204Prostatic Neoplasms
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Gothenburg, ร–rebro, Stockholm, Umeรฅ, Uppsala
2013-10-14
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Swedish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-sweden/condition/prostatic-neoplasms

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Sweden and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,213 studies in total at the last sync on 26 Sep 2026, 19:46 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies listing the condition Prostatic Neoplasms.

How many Prostatic Neoplasms trials are recruiting in Sweden?

4 of the 11 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:46 UTC sync. A further 0 have not yet opened recruitment, 7 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Prostatic Neoplasms), 11 studies
PhaseStudiesRecruitingShare
Phase 38272.7%
Not applicable119.1%
Observational119.1%
Phase 1109.1%

Most active sponsors

Lead sponsors with the most studies (Prostatic Neoplasms)
Lead sponsorStudiesRecruiting
Aragon Pharmaceuticals, Inc.20
Janssen Research & Development, LLC20
Merck Sharp & Dohme LLC22
Novartis Pharmaceuticals20
Janssen Pharmaceutica N.V., Belgium10
Olof Akre11
Vastra Gotaland Region11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.